Quest Diagnostics issues $750M of 6.400% senior notes due 2033

QUEST DIAGNOSTICS INC

$750M aggregate principal; 6.400% coupon; mature Nov 30, 2033; interest paid semi-annually May 30 & Nov 30.
Proceeds for general corporate purposes, may redeem/repay $300M of 4.25% senior notes due 2024 and credit facility borrowings.
Offering priced Oct 30, 2023; closed Nov 1, 2023; joint book-runners Goldman Sachs, Mizuho, Morgan Stanley.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

QUEST DIAGNOSTICS INC entered into Indenture with The Bank of New York Mellon valued at $750,000,000 aggregate principal amount (effective 2023-11-01).

Action: entry
Agreement: notes offering
Counterparty: The Bank of New York Mellon
Value: $750,000,000 aggregate principal amount
Effective: 2023-11-01

Exact text from the filing

On November 1, 2023, Quest Diagnostics Incorporated (the “Company”) issued $750,000,000 aggregate principal amount of 6.400% senior notes due 2033 (the “Notes”).

View on SEC.gov

Browse all material agreements →

QUEST DIAGNOSTICS INC filing history →

Source: SEC EDGAR

accession 0001022079-23-000172

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.